Huajian Medical Seeks Approval for Cryptocurrency Purchase Program

Hong Kong-listed company Huajian Medical (01931.HK) has unveiled plans to seek shareholder approval for a cryptocurrency purchase program. The board views the acquisition and holding of cryptocurrencies as essential for bolstering its Ethereum (ETH) reserves and supporting the development of the ivd.xyz trading platform ecosystem. This initiative is also considered integral to the group’s asset allocation strategy. 01931.HK proposes obtaining shareholder approval for this program, enabling a formal resolution at a special meeting that would allow potential cryptocurrency purchases within a 36-month period, with a maximum purchase amount of HK$3 billion.